Phase I trial of irritation potential of anti-GATA3-gene-therapy emulsion in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2014
Price : $35 *
At a glance
- Drugs Anti-GATA3 gene-therapy (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors sterna biologicals
- 11 Mar 2014 New trial record
- 06 Mar 2014 Top-line results reported in a sterna biologicals media release.